BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30 AND Staging
10 results:

  • 1. A revised international prognostic score system for Waldenström's macroglobulinemia.
    Kastritis E; Morel P; Duhamel A; Gavriatopoulou M; Kyrtsonis MC; Durot E; Symeonidis A; Laribi K; Hatjiharissi E; Ysebaert L; Vassou A; Giannakoulas N; Merlini G; Repousis P; Varettoni M; Michalis E; Hivert B; Michail M; Katodritou E; Terpos E; Leblond V; Dimopoulos MA
    Leukemia; 2019 Nov; 33(11):2654-2661. PubMed ID: 31118465
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Using prognostic models in CLL to personalize approach to clinical care: Are we there yet?
    Mina A; Sandoval Sus J; Sleiman E; Pinilla-Ibarz J; Awan FT; Kharfan-Dabaja MA
    Blood Rev; 2018 Mar; 32(2):159-166. PubMed ID: 29122300
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Lymphoma of the Cervix: Case Report and Review of the Literature.
    Hilal Z; Hartmann F; Dogan A; Cetin C; Krentel H; Schiermeier S; Schultheis B; Tempfer CB
    Anticancer Res; 2016 Sep; 36(9):4931-40. PubMed ID: 27630351
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic factors and risk stratification in chronic lymphocytic leukemia.
    Parikh SA; Shanafelt TD
    Semin Oncol; 2016 Apr; 43(2):233-40. PubMed ID: 27040701
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis.
    Parikh SA; Strati P; Tsang M; West CP; Shanafelt TD
    Blood; 2016 Apr; 127(14):1752-60. PubMed ID: 26841802
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
    Miles RR; Arnold S; Cairo MS
    Br J Haematol; 2012 Mar; 156(6):730-43. PubMed ID: 22260323
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Chronic lymphocytic leukaemia: an autoimmune disorder? Prognostic factors and the current view of pathogenesis].
    Pajor L
    Orv Hetil; 2007 May; 148(19):867-78. PubMed ID: 17478402
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients.
    Warzynski MJ; Graham DM; Axtell RA; Higgins JV; Hammers YA
    Cytometry; 2002 Dec; 50(6):298-304. PubMed ID: 12497591
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. New aspects on the pathogenesis, diagnostic procedures, and therapeutic management of chronic lymphocytic leukemia.
    Wendtner CM; Schmitt B; Bergmann M; Röhnisch T; Buhmann R; Hallek M
    Int J Hematol; 2001 Jan; 73(1):32-8. PubMed ID: 11372752
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.